Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2373087
Max Phase: Preclinical
Molecular Formula: C50H61N9O8
Molecular Weight: 916.09
Molecule Type: Protein
Associated Items:
ID: ALA2373087
Max Phase: Preclinical
Molecular Formula: C50H61N9O8
Molecular Weight: 916.09
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](NC(C)=O)C1c2ccccc2CCc2ccccc21)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
Standard InChI: InChI=1S/C50H61N9O8/c1-6-29(4)44(48(64)58-41(50(66)67)22-33-24-52-38-18-12-11-15-35(33)38)59-42(61)26-53-46(62)40(23-34-25-51-27-54-34)56-47(63)39(21-28(2)3)57-49(65)45(55-30(5)60)43-36-16-9-7-13-31(36)19-20-32-14-8-10-17-37(32)43/h7-18,24-25,27-29,39-41,43-45,52H,6,19-23,26H2,1-5H3,(H,51,54)(H,53,62)(H,55,60)(H,56,63)(H,57,65)(H,58,64)(H,59,61)(H,66,67)/t29-,39-,40-,41-,44-,45+/m0/s1
Standard InChI Key: KKXOTMSGRHEYHS-PAUZEOSASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 916.09 | Molecular Weight (Monoisotopic): 915.4643 | AlogP: 3.34 | #Rotatable Bonds: 21 |
Polar Surface Area: 256.37 | Molecular Species: ACID | HBA: 8 | HBD: 9 |
#RO5 Violations: 2 | HBA (Lipinski): 17 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.10 | CX Basic pKa: 6.53 | CX LogP: 2.38 | CX LogD: 1.46 |
Aromatic Rings: 5 | Heavy Atoms: 67 | QED Weighted: 0.05 | Np Likeness Score: -0.11 |
1. Neustadt B, Wu A, Smith E, Nechuta T, Fawzi A, Zhang H, Ganguly A. (1995) A case study of combinatorial libraries: Endothelin receptor antagonist hexapeptides, 5 (17): [10.1016/0960-894X(95)00349-X] |
Source(1):